
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma
Xuebing Zhou, Yuan Li, Chunyu Yang, et al.
Life Sciences (2023) Vol. 327, pp. 121698-121698
Closed Access | Times Cited: 11
Xuebing Zhou, Yuan Li, Chunyu Yang, et al.
Life Sciences (2023) Vol. 327, pp. 121698-121698
Closed Access | Times Cited: 11
Showing 11 citing articles:
Neutrophil-mediated cordycepin-based nanoparticles for targeted treatment of acute lung injury
Michael Gao, Huizhen Fan, YU Sen-yang, et al.
Chemical Engineering Journal (2025), pp. 159942-159942
Closed Access
Michael Gao, Huizhen Fan, YU Sen-yang, et al.
Chemical Engineering Journal (2025), pp. 159942-159942
Closed Access
Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway
Qi Chen, Jiayu Guo, Shangting Han, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114264-114264
Closed Access
Qi Chen, Jiayu Guo, Shangting Han, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114264-114264
Closed Access
Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
Jianfeng Yang, Kaiyi Ruan, Zhaowei Chu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Jianfeng Yang, Kaiyi Ruan, Zhaowei Chu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Application and research progress of cordycepin in the treatment of tumours (Review)
Ru He, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 3
Ru He, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 3
Synthesis and Antitumor Activity Study of Novel Formononetin Derivatives
Ze-Ping Luo, Liwei Pan, Xiu‐Ju Yin, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 313-327
Closed Access | Times Cited: 2
Ze-Ping Luo, Liwei Pan, Xiu‐Ju Yin, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 313-327
Closed Access | Times Cited: 2
MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing
Tian Huang, Hengsong Cao, Chuan Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 2
Tian Huang, Hengsong Cao, Chuan Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 2
Insights into the methods for Separation and Chromatographic Determination of Nucleotides/Nucleosides in Cordyceps spp.
Ting Peng, Xiaoxing Li, Xinxin Tong
Journal of Chromatography A (2024) Vol. 1734, pp. 465279-465279
Closed Access | Times Cited: 1
Ting Peng, Xiaoxing Li, Xinxin Tong
Journal of Chromatography A (2024) Vol. 1734, pp. 465279-465279
Closed Access | Times Cited: 1
Cordycepin Enhances the Anticancer Efficacy of PD-L1 Blockade by Modulating the Tumor Microenvironment of Colon Cancer
Chen Feng, Rongzhang Chen, Xinran Gao, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177089-177089
Closed Access | Times Cited: 1
Chen Feng, Rongzhang Chen, Xinran Gao, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177089-177089
Closed Access | Times Cited: 1
ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer
Maria A. Voronkova, Brent A. Johnson, Nishant Gandhi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Maria A. Voronkova, Brent A. Johnson, Nishant Gandhi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Identification of prognostic biomarkers for cholangiocarcinoma by combined analysis of molecular characteristics of clinical MVI subtypes and molecular subtypes
Mingyue Li, Yahui Liu, Wei Feng, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110889-110889
Open Access
Mingyue Li, Yahui Liu, Wei Feng, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110889-110889
Open Access
Cordycepin Enhanced Therapeutic Potential of Gemcitabine against Cholangiocarcinoma via Downregulating Cancer Stem-Like Properties
Hong Kyu Lee, Yun-Jung Na, Su‐Min Seong, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 368-378
Open Access
Hong Kyu Lee, Yun-Jung Na, Su‐Min Seong, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 368-378
Open Access